Molecular Mimicry Mapping in Streptococcus pneumoniae: Cues for Autoimmune Disorders and Implications for Immune

Mutaib M Mashraqi1, Ahmad Alzamami2, Norah A Alturki3

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran 61441, Saudi Arabia.

PubMed

Insights

Streptococcus pneumoniae infections may trigger autoimmunity through molecular mimicry. This study identified bacterial protein mimics linked to human autoimmune diseases, paving the way for novel vaccine development against pneumococcal infections.

Area of Science:

  • Microbiology
  • Immunology
  • Bioinformatics

Background:

  • Streptococcus pneumoniae causes serious infections like meningitis and pneumonia.
  • Bacterial infections can induce autoimmunity via molecular mimicry, where pathogen proteins resemble host proteins.

Purpose of the Study:

  • To investigate the potential of Streptococcus pneumoniae to trigger autoimmunity using molecular mimicry.
  • To identify bacterial proteins with sequence similarity to human proteins involved in autoimmune disorders.
  • To explore the development of a mimic-based vaccine against S. pneumoniae.

Main Methods:

  • Bioinformatic analysis to identify S. pneumoniae proteins similar to human proteins.
  • In silico tools to predict sequence and structural homology.
  • Database mining to link bacterial proteins to autoimmune diseases.
  • Design and validation of a vaccine construct using identified mimics.

Main Results:

  • Identified 13 S. pneumoniae proteins with significant sequence similarity to human proteins.
  • Eleven of these proteins are linked to autoimmune disorders like rheumatoid arthritis and diabetes.
  • A vaccine construct (C8) showed promising binding affinity to HLA molecules and TLR4.
  • Mimics were mapped to conserved regions, suggesting functional importance in pathogenesis.

Conclusions:

  • Streptococcus pneumoniae has the potential to induce autoimmunity through molecular mimicry.
  • Identified mimics can be used to design effective vaccines against S. pneumoniae infections.
  • This approach may also offer insights into the mechanisms of autoimmune disease development.